Unknown

Dataset Information

0

Structural basis for broad coronavirus neutralization.


ABSTRACT: Three highly pathogenic β-coronaviruses crossed the animal-to-human species barrier in the past two decades: SARS-CoV, MERS-CoV and SARS-CoV-2. SARS-CoV-2 has infected more than 64 million people worldwide, claimed over 1.4 million lives and is responsible for the ongoing COVID-19 pandemic. We isolated a monoclonal antibody, termed B6, cross-reacting with eight β-coronavirus spike glycoproteins, including all five human-infecting β-coronaviruses, and broadly inhibiting entry of pseudotyped viruses from two coronavirus lineages. Cryo-electron microscopy and X-ray crystallography characterization reveal that B6 binds to a conserved cryptic epitope located in the fusion machinery and indicate that antibody binding sterically interferes with spike conformational changes leading to membrane fusion. Our data provide a structural framework explaining B6 cross-reactivity with β-coronaviruses from three lineages along with proof-of-concept for antibody-mediated broad coronavirus neutralization elicited through vaccination. This study unveils an unexpected target for next-generation structure-guided design of a pan-coronavirus vaccine.

SUBMITTER: Sauer MM 

PROVIDER: S-EPMC7781312 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3202596 | biostudies-literature
| S-EPMC6402988 | biostudies-literature
| S-EPMC8043460 | biostudies-literature
| S-EPMC7253169 | biostudies-literature
| S-EPMC6096824 | biostudies-literature
| S-EPMC2981354 | biostudies-literature
| S-EPMC6158212 | biostudies-literature
| S-EPMC5730766 | biostudies-literature
| S-EPMC6854463 | biostudies-literature
| S-EPMC3347318 | biostudies-literature